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EVALUATION OF PSEUDOPROGRESSION
IN PATIENTS WITH GLIOBLASTOMA
MULTIFORME
USING
DYNAMIC
MAGNETIC RESONANCE IMAGING WITH
FERUMOXYTOL CALLS RANO CRITERIA
INTO QUESTION.[6]
Study Question: Study Question: Does the Response
Assessment in Neuro-Oncology (RANO) criteria
adequately evaluate for pseudoprogression following
chemoradiation for the treatment of glioblastoma?
The authors of this study aim to evaluate the role of
magnetic resonance imaging (MRI) with ferumoxytol
in the diagnosis of pseudoprogression after treatment
of glioblastoma. Current treatment standards include
maximal safe surgical resection followed by concomitant
temozolomide and conformal radiation. In general, the
risk of posttreatment radiation necrosis is approximately
5–30% and presents typically between 3 and 18 months

posttreatment. However, radiation necrosis has been
reported decades after initial therapy. Currently, the
RANO criteria is one of the most widely used criteria
to assess treatment response within clinical trials. The
criteria for true pseudoprogression require pathological
confirmation or new lesions outside the radiation
field within 12 weeks of treatment. Outside of these
stipulations, pseudoprogression can only be classified as a
possible diagnosis.
In an effort to better define pseudoprogression, the
authors evaluated 56 glioblastoma patients with
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conventional MRI findings concerning for progression of
disease. The authors used a 3 Tesla ferumoxytol‑based
perfusion MRI to assess relative cerebral blood
volume measurements with areas concerning for
progression normalized to normal appearing white
matter. Based on prior data, a threshold of 1.75 was
used as a cutoff for differentiating pseudoprogression
from progressive disease. The authors identified
48% of patients with pseudoprogression. Of these
patients with pseudoprogression, 30% displayed this
finding greater than 3 months after the completion of
treatment. Furthermore, overall survival was significantly
longer (35.2 vs. 14.3 months, P < 0.001) in patients with
pseudoprogression as compared with progressive disease.
The role of ferumoxytol‑based MRI is a valuable tool
in diagnosing pseudoprogression without biopsy. The
authors effectively displayed the value of diagnosing
this condition with regard to overall survival and
demonstrated that pseudoprogression is frequent beyond
3 months.
Perspective: This study provides insight in to the
current limitations of the RANO criteria. Consequently,
radiographic worsening beyond 3 months does not
indicate definitive tumor progression. Currently, the
RANO criteria are the primary measure by which
clinical trials are evaluated for tumor control versus
progression. Dynamic MRI provides an additional
diagnostic tool outside of open biopsy in delineating
between pseudoprogression and tumor progression.
Therefore, relative cerebral blood volume measurement
through ferumoxytol MRI should be considered in the
diagnosis of progression through the RANO criteria.
Future prospective studies with larger cohorts will serve
to further validate the results seen in this study.
Summary Written by: Johnathan H Sherman MD

C2 NERVE ROOT TRANSECTION DURING C1
LATERAL MASS SCREW FIXATION: DOES IT
AFFECT FUNCTIONALITY AND QUALITY
OF LIFE?[2]
Study Question: How does C2 nerve root transection
during C1 lateral mass placement affect functionality and
quality of life?
The authors conducted a 2‑year prospective study on
patients undergoing posterior atlantoaxial arthrodesis
using the standard Harms and Melcher technique that
involves the placement of C1 lateral mass polyaxial
screws as well as either pars interarticularis, or pedicle
screws at C2. Twenty‑eight patients were enrolled in this
study. Eight of these patients had their C2 nerve roots
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transected during C1 lateral mass screw placement,
while in 20 patients the C2 nerve roots were preserved.
A standard questionnaire was used to determine the
presence, severity and frequency of occipital numbness/
pain, and its effects on functionality and quality of
life (QOL). In addition domains of the neck disability
index (NDI) were used to quantify physical disability
specific to occipital numbness. While there were
trends towards lower estimated blood loss (338 vs.
235 ml), and lower length of surgery (167 vs. 153 min)
favoring the nerve severing group, these did not
achieve statistical significance. Regarding postoperative
outcomes, occipital numbness was reported by 50%
of patients following C2 transection, while occipital
neuralgia was reported by 35% of patients with C2
preservation. None of the patients with numbness
after C2 transection reported being “bothered” by it,
while all patients with occipital neuralgia following
C2 sparing reported being “bothered” by it and, 57.1%
reported a moderate‑to‑severe effect on QOL. A total
of 71.4% of patients with neuralgia reported the use of
medications while none of the patients with numbness
used any medications. Lastly, the mean disability
was significantly higher with neuralgia compared to
numbness (P = 0.016).
Perspective: The Harms and Melcher technique is the
most commonly used method for posterior C1 and C2
stabilization that utilizes the placement of polyaxial
screws into the C1 lateral masses. The entry point for
C1 screw placement is usually in the middle of the
lateral mass at the level of an unnamed emissary vein.
In order to expose it, subperiosteal dissection is often
conducted along the posterior arch of C1 and then
deeper into the lateral mass. This is oftentimes tedious
and obscured by bleeding from the vertebral venous
plexus and by the presence of theC2 nerve root. Goel
et al.[3] have pursued sectioning of the C2 nerve roots
bilaterally proximal to the C2 ganglion, advocating that
it enhances exposure, reduces bleeding, and allows for
the opportunity for direct C1/C2 joint decortication,
and hence arthrodesis. This study was the first
prospective study to examine the effects of sacrificing
the C2 root on the QOL and functionality in patients
undergoing C1 lateral mass screw placement. While
this study is limited by a small number of patients
and the absence of preoperative and bassline outcome
measures, it demonstrates the safety of C2 nerve root
transection during these procedures. In fact, while C2
transection is associated with occipital numbness, this
had no effect on QOL. On the other hand, C2 sparring
was associated with occipital neuralgia that had
negative effects on patient disability and QOL.
Summary Written by: Nader S. Dahdaleh MD
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LONG‑TERM QUALITY OF LIFE IN PATIENTS
WITH
VESTIBULAR
SCHWANNOMA:
AN
INTERNATIONAL
MULTICENTER
CROSS‑SECTIONAL STUDY COMPARING
MICROSURGERY,
STEREOTACTIC
RADIOSURGERY,
OBSERVATION,
AND
[1]
NONTUMOR CONTROLS.
Study Question: How do microsurgery, stereotactic
radiosurgery, and observation affect long‑term quality
of life in patients with small‑ to medium‑size vestibular
schwannomas?
The authors[1] conducted a cross‑sectional study examining
long‑term health‑related quality of life (HRQOL)
in a large cohort of patients following observation,
microsurgery, and stereotactic radiosurgery (SRS)
for small‑ to medium‑sized sporadic vestibular
schwannomas (VSs) using three multipurpose HRQOL
questionnaires and one recently validated disease‑specific
instrument. All patients with smaller than 3‑cm sporadic
VSs who underwent microsurgery, SRS or observation at
one of two tertiary academic referral centers, one located
in the United States and one in Western Europe, between
1998 and 2008 were surveyed via postal questionnaire
using the 36‑Item Short Form Health Survey (SF‑36),
the 10‑item Patient‑Reported Outcomes Measurement
Information System short form (PROMIS‑10), the
Glasgow Benefit Inventory (GBI), and the Penn Acoustic
Neuroma Quality‑of‑Life (PANQOL) scale. A total of
642 respondents were analyzed: 144 microsurgery, 247
SRS, and 148 observation patients in addition to 103
nontumor control patients. The mean interval between
treatment and survey for patients with VS was 7.7 years.
A multivariate regression model found no difference
between management groups with respect to the
PROMIS‑10 physical or mental health dimensions, the
SF‑36 Physical or Mental Component Summary scores,
or the PANQOL general, anxiety, hearing, or energy
subdomains. SRS treatment or observation resulted
in a better total PANQOL score and higher PANQOL
facial, balance, and pain subdomain scores than the
microsurgical cohort (P < 0.02). The nontumor control
group and patients with VS had a greater difference in
scores than the differences observed between individual
treatment groups for the majority of measures.
Perspective: This study was the first multicenter study
evaluating HRQOL in VS, includes the largest number
of patients to date with the longest follow‑up, compared
HRQOL outcomes between all three management
arms, and used three general HRQOL instruments and
a recently validated disease‑specific questionnaire that
minimized the risk of monomethod bias. The authors
found that the differences in HRQOL outcomes
following SRS, observation, and microsurgery for VS
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are small, and the diagnosis of VS rather than the
treatment strategy more significantly impacts QOL.
Importantly, improvements in patient counseling
regarding realistic long‑term expectations of disease and
offering psychosocial support may provide the most
impact on HRQOL improvement. Given these findings
together with the fact that many VSs remain stable in
size following discovery, VSs less than 3‑cm in size should
be managed with observation initially, with intervention
reserved for unequivocal growth or intractable symptoms
that are amenable to treatment. The management of
small‑ to medium‑sized VS cannot be “one size fits all.” A
personalized management approach must be undertaken
for each patient, taking into account tumor size and
characteristics, patient age and health, symptoms, and
patient preference.
Summary Written by: Isaac Yang, MD and Panayiotis
Pelargos

ENDOSCOPIC THIRD VENTRICULOSTOMY
AND CHOROID PLEXUS CAUTERIZATION
IN INFANTS WITH HYDROCEPHALUS:
A
RETROSPECTIVE
HYDROCEPHALUS
CLINICAL RESEARCH NETWORK STUDY.[4]
Study Question: What are the outcomes of endoscopic
third ventriculostomy and choroid plexus cauterization
(ETV + CPC) for treatment of pediatric hydrocephalus
in a North American population?
Children aged <2 years old in the Hydrocephalus Clinical
Research Network multi‑institutional registry who underwent
ETV + CPC before November 2012 were included in
the study. Outcomes and morbidity were retrospectively
examined for ETV + CPC patients and for age‑matched
children who had first‑time ventriculoperitioneal shunt
placement for hydrocephalus. Included were 36 patients
who underwent ETV + CPC, of which 13 patients had a
history of previous shunt. These 36 ETV + CPC patients
had the following hydrocephalus etiologies: Intraventricular
hemorrhage of prematurity (9 patients), aqueductal
stenosis (8), myelomeningocele (4), and other (15). Time
to first treatment failure (requiring another surgery for
hydrocephalus) was defined as the primary outcome. Fifty
percent of the 36 ETV + CPC patients failed. Failure
occurred at a median time of 30 days (4–484 days) after
ETV + CPC surgery.
ETV + CPC success rates at 3‑, 6‑, and 12‑months after
surgery were 58%, 52%, and 52%, respectively. Using the
validated ETV Success Score to calculate the predicted
rate of success for the group, the expected success
rate of ETV‑only surgery for this cohort overall would
be 50%. The authors note some limited evidence for
improved outcome for patients who received ETV with
near‑complete (≥90%) choroid plexus cauterization,
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suggesting that the effect of CPC may have a dose–
response effect.
This early North American multicenter experience reports
on 36 infants with ETV + CPC. Overall outcomes at
6 months are similar to ETV alone. Treatment in half of
all patients failed, with median time to failure of 30 days.
ETV + CPC is shown in this study to be a reasonably
safe alternative to cerebrospinal fluid (CSF) shunt
placement for infants with hydrocephalus. There was no
independent adjudication of outcome, so there may be
bias in the decisions regarding subsequent CSF diversion
following the index surgery. The ages of the ETV + CPC
and shunt patients were not quite comparable, with the
ETV + CPC patients being older.
Perspective: The Hydrocephalus Clinical Research
Network (HCRN) is a tightly controlled group
representing highly specialized Pediatric Neurosurgery
centers in North America. They present the retrospective
experience of HCRN members with ETV + CPC in
North America, and they report less optimistic outcomes
than Dr. Benjamin Warf’s experiences in East Africa.
They report that the ETV + CPC surgery is safe, though
they do report a higher failure rate than known CSF
shunt placement failure rates. It remains to be seen how
to weigh the chance at shunt freedom with ETV + CPC
with its higher failure rate, given the known lifelong
burden of CSF shunting. Neurocognitive outcomes
and long‑term outcomes are not well‑characterized to
date. What is the acceptable differential in outcomes
for surgeons and patients, given the known downstream
burden of CSF shunts and possible downstream sequelae
of ETV + CPC? Many questions remain. A prospective
ETC + CPC study is planned by the HCRN, which
hopefully will further delineate the role of ETV + CPC
in the treatment of pediatric hydrocephalus in North
America.
Summary Written by: By Sandi Lam MD

INTERSPINOUS
PROCESS
DEVICES
VERSUS
STANDARD
CONVENTIONAL
DECOMPRESSION FOR LUMBAR SPINAL
STENOSIS: COST‑UTILITY ANALYSIS.[7]
Study Question: Is the use of an interspinous
fixation clamp cost effective when compared with
noninstrumented lumbar decompression?
The authors studied patients with intermittent neurogenic
claudication, including patients aged 40–85 and with one
or two level lumbar canal disease. This was a multi‑center,
double‑blinded randomized trial. Over a 35‑month
period, 161 patients were enrolled and 159 analyzed.
This included enrollment at five separate neurosurgical
centers, including one academic and four secondary
centers. Eighty patients were treated with an interspinous
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process device (IPD) and 79 had traditional lumbar
decompression without instrumention. Outcome measures
included quality‑adjusted life years (QALYs), estimated
societal cost per year (estimated from The Netherlands
EuroQol 5D [EQ‑5D) and EuroQol visual analog score,
and diaries of cost). This was a registered trial in the
Netherlands (Dutch Trial Register Number: NTR1307).
The results of this trail failed to show valuation in the
use of an IPD device. According to the EQ‑5D results,
the valuation of life after implantation of the IPD
versus standard decompression was not different. Mean
utilities were less favorable after the IPD according to
EQ‑5D with a difference in QALY of 0.024 (confidence
interval [CI]: ‑0.031 to 0.079). Overall, the cost of
IPD placement was higher with an increase of 3030
Euro per patient (95% CI: 561–5498 Euro). This was
primarily from implant cost (2350 Euro per implant).
As a result, from a societal perspective, there was
a 2762 Euro difference in favor of traditional bony
decompression.
Perspective:
Lumbar
spinal
decompression
for
intermittent neurogenic claudication is an extremely
effective and durable procedure in patients with
progressive symptoms that fail to respond to conservative
care. To improve upon this procedure, any new
technique must be both more effective and equally
safe. Furthermore, the additional placement of spinal
instrumention (and its resultant extra cost) must be
carefully evaluated. This is especially important in our
current health‑care environment where procedural and
societal costs from surgical procedures are under intense
scrutiny.
The efficacy of IPDs has not yet been well
established.[8] They have not been shown to improve
outcomes when compared with traditional lumbar
decompression.[5] Furthermore, in patients without
spinal instability, such as in the current study, one must
question the biomechanical or clinical benefit of adding
these devices in an already effective and established
surgery. Although we acknowledge the ultimate goal of
improving our day‑to‑day techniques, the significant
added cost of these devices requires a matching clinical
benefit.
Summary Written by: Zachary A. Smith, M.D.
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